Reportedly, systemic administration of the ErbB4 ligand neuregulin-1 protected dopaminergic neurons in a mouse model of Parkinson’s disease [30], and constitutively active neuronal c-Abl overexpression resulted in neurodegeneration [31]. This evidence concerns the gene NRG1 and Parkinson disease.